Insider Transactions in Q2 2021 at Jazz Pharmaceuticals PLC (JAZZ)
Insider Transaction List (Q2 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 05
2021
|
Kim Sablich EVP, GM of U.S. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,452
-5.73%
|
$255,552
$176.47 P/Share
|
Jun 05
2021
|
Robert Iannone EVP, Global Head of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
1,206
-3.98%
|
$212,256
$176.47 P/Share
|
Jun 01
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,750
-0.54%
|
$313,250
$179.07 P/Share
|
May 05
2021
|
Christopher J. Tovey EVP, COO & Managing Director E |
BUY
Grant, award, or other acquisition
|
Direct |
9,091
+49.93%
|
-
|
May 05
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
500
-0.16%
|
$85,000
$170.0 P/Share
|
May 03
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,500
-0.46%
|
$246,000
$164.24 P/Share
|
Apr 05
2021
|
Renee D Gala President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,515
-5.64%
|
$248,460
$164.71 P/Share
|
Apr 01
2021
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,500
-0.46%
|
$246,000
$164.96 P/Share
|